References
- Cardozo ER, Clark AD, Banks NK. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206:211.e1–211.e9.
- Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med. 2010;28:204–217.
- Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2005;105:217.
- Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–107.
- Lagana AS, Vergara D, Favilli A, et al. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch Gynecol Obstet. 2017;296:855–867.
- Vitale SG, Padula F, Gulino FA. Management of uterine fibroids in pregnancy: recent trends. Curr Opin Obstet Gynecol. 2015;27:432–437.
- Ciavattini A, Di Giuseppe J, Stortoni P, et al. Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int. 2013;2013:1–184.
- Borah BJ, Nicholson WK, Bradley L, et al. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013;209:319.e1–319.e20.
- Khan AT, Shehmar M, Gupta JK. Uterine fibroids: current perspectives. Int J Womens Health. 2014;6:95–114.
- Ghant MS, Sengoba KS, Recht H, et al. Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women’s emotional and psychosocial health. J Psychosom Res. 2015;78:499–503.
- Knudsen NI, Wernecke KD, Siedentopf F, et al. Fears and concerns of patients with uterine fibroids - a survey of 807 women. Geburtshilfe Frauenheilkd. 2017;77:976–983.
- Brito LGO, Panobianco MS, Sabino-de-Freitas MM, et al. Uterine leiomyoma: understanding the impact of symptoms on womens’ lives. Reprod Health. 2014;11:10.
- Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99:290–300.
- Gallicchio L, Harvey LA, Kjerulff KH. Fear of cancer among women undergoing hysterectomy for benign conditions. Psychosom Med. 2005;67:420–424.
- Utz-Billing IR, Rothmann K, Kentenich H, et al. Prätherapeutische angste, erwartungen, wünsche und informiertheit von frauen mit uterus myomatosus. [Pretherapeutic anxiety, expectations, wishes, and informedness of women with Uterus myomatosus.]. Geburtsh Frauenheilk. 2006;66:763–768.
- Nevadunsky NS, Bachmann GA, Nosher J, et al. Women’s decision-making determinants in choosing uterine artery embolization for symptomatic fibroids. J Reprod Med. 2001;46:870–874.
- Kjerulff KH, Langenberg PW, Rhodes JC, et al. Effectiveness of hysterectomy. Obstet Gynecol. 2000;95:319–326.
- Charite – Universitätsmedizin Berlin. Neufassung der Satzung der Charité – Universitätsmedizin Berlin zur Sicherung Guter Wissenschaftlicher Praxis vom 20.06.2012 (AMB Charité Nr. 092, S. 658) [New Edition of the Guidelines of the Charité University Hospital to Ensure Good Scientific Practice, from June 20, 2012 (AMB Charité #. 092, p. 658)]. Available from: https://www.charite.de/fileadmin/user_upload/portal/charite/presse/publikationen/amtlmitteilungsblatt/2018/AMB180329-208.pdf
- Laux LG, Schaffner P, Spielberger CD. STAI – das state-trait- angstinventar – theoretische grundlagen und handanweisungen. [The state-trait anxiety inventory – theoretical foundations and practical instructions.] Göttingen, Germany: Beltz Test GmbH; 1981.
- Giesinger J, Rumpold MG, Schüßler G. Die K10-screening-skala für unspezifischen psychischen distress. [The K10 screening scale for unspecific mental distress.]. Psychosom Konsiliarpsychiatr. 2008;2:104–111.
- Andrews G, Slade T. Interpreting scores on the Kessler psychological distress scale (K10). Aust N Z J Public Health. 2001;25:494–497.
- Kessler RC, Andrews G, Colpe LJ, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32:959–976.
- Furukawa TA, Kessler RC, Slade T, et al. The performance of the K6 and K10 screening scales for psychological distress in the Australian national survey of mental health and well-being. Psychol Med. 2003;33:357–362.
- Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian national mental health survey. Br J Psychiatry. 2001;178:145–153.
- Divakar H. Asymptomatic uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22:643–654.
- Kannenberg K, Weichert J, Rody A, et al. Treatment-associated anxiety among pregnant women and their partners: what is the influence of sex, parity, age and education? Geburtshilfe Frauenheilkd. 2016;76:809–813.
- Jacobi F, Höfler M, Strehle J, et al. Psychische störungen in der allgemeinbevölkerung. [Mental disorders in the general population.]. Nervenarzt. 2014;85:77–87.
- Nicholls C, Glover L, Pistrang N. The illness experiences of women with fibroids: an exploratory qualitative study. J Psychosom Obstet Gynaecol. 2004;25:295–304.
- Lixia L ,Lan H ,Yun D. The correlation of stress response, psychological state and prognosis in the different treatments of uterine fibroids. Biomed Res. 2017;28:16.
- Sepulcri Rde P, do Amaral VF. Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol. 2009;142:53–56.
- Cavaggioni G, Lia C, Resta S, et al. Are mood and anxiety disorders and alexithymia associated with endometriosis? A preliminary study. Biomed Res Int. 2014;2014:1.
- Shen TC, Yang CY, Huang YJ, et al. Risk of depression in patients with uterine leiomyoma: a nationwide population-based cohort study. J Affect Disord. 2017;213:126–130.
- Lawson AK, Klock SC, Pavone ME, et al. Prospective study of depression and anxiety in female fertility preservation and infertility patients. Fertil Steril. 2014;102:1377–1384.
- Ghant MS, Sengoba KS, Vogelzang R, et al. An altered perception of normal: understanding causes for treatment delay in women with symptomatic uterine fibroids. J Womens Health (Larchmt). 2016;25:846–852.
- Downes E, Sikirica V, Gilabert-Estelles J, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol. 2010;152:96–102.
- Ekpo GE, Ghant MS, Woodley LM, et al. Knowledge of uterine fibroid symptoms and presentation among African-American women: a pilot study. J Reprod Med. 2014;59:448–454.
- Muse K, McManus F, Leung C, et al. Cyberchondriasis: fact or fiction? A preliminary examination of the relationship between health anxiety and searching for health information on the Internet. J Anxiety Disord. 2012;26:189–196.
- Handelzalts JE, Levy S, Peled Y, et al. Information seeking and perceptions of anxiety and pain among women undergoing hysterosalpingography. Eur J Obstet Gynecol Reprod Biol. 2016;202:41–44.
- Glowinska A, Zielona-Jenek M, Pawelczyk A. Determinants of emotional problems and mood disorders in women with polycystic ovary syndrome. Ginekol Pol. 2016;87:405–410.
- Borghi L, Leone D, Vegni E, et al. Psychological distress, anger and quality of life in polycystic ovary syndrome: associations with biochemical, phenotypical andsocio-demographic factors. J Psychosom Obstet Gynaecol. 2018;39:128–137.
- Lagana AS, La Rosa VL, Rapisarda AMC, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health. 2017;9:323–330.
- Pope CJ, Sharma V, Sharma S, et al. A systematic review of the association between psychiatric disturbances and endometriosis. J Obstet Gynaecol Can. 2015;37:1006–1015.
- Benson S, Hahn S, Tan S, et al. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod. 2009;24:1446–1451.
- Williams VSL, Jones G, Mauskopf J, et al. Uterine fibroids: a review of health-related quality of life assessment. J Womens Health (Larchmt). 2006;15:818–829.
- Vitale SG, Sapia F, Rapisarda AMC, et al. Hysteroscopic morcellation of submucous myomas: a systematic review. Biomed Res Int. 2017;2017:6848250.
- Vitale SG, Tropea A, Rossetti D, et al. Management of uterine leiomyomas in pregnancy: review of literature. Updates Surg. 2013;65:179–182.
- Parazzini F, Tozzi L, Bianchi S. Pregnancy outcome and uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2016;34:74–84.
- Milazzo GN, Catalano A, Badia V, et al. Myoma and myomectomy: poor evidence concern in pregnancy. J Obstet Gynaecol Res. 2017;43:1789–1804.
- Stewart EA. Uterine fibroids. Lancet. 2001;357:293–298.
- Osuga Y, Enya K, Kudou K, et al. Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injections for uterine leiomyomas: a randomized controlled trial. Obstet Gynecol. 2019;133:423–433.
- Zhao L, Wu H, Zhou X, et al. Effects of progressive muscular relaxation training on anxiety, depression and quality of life of endometriosis patients under gonadotrophin-releasing hormone agonist therapy. Eur J Obstet Gynecol Reprod Biol. 2012;162:211–215.
- Vitale SG, Lagana AS, Noventa M, et al. Transvaginal bilateral sacrospinous fixation after second recurrence of vaginal vault prolapse: efficacy and impact on quality of life and sexuality. Biomed Res Int. 2018;2018:1.
- Vitale SG, Caruso S, Rapisarda AM, et al. Biocompatible porcine dermis graft to treat severe cystocele: impact on quality of life and sexuality. Arch Gynecol Obstet. 2016;293:125–131.
- Dilek S, Ertunc D, Tok EC, et al. The effect of myomectomy on health-related quality of life of women with myoma uteri. J Obstet Gynaecol Res. 2010;36:364–369.
- Voogt MJ, De Vries J, Fonteijn W, et al. Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids. Fertil Steril. 2009;92:756–761.
- Tuschy B, Gabbert M, Weiss C, et al. Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2018;228:106–110.
- Marsh EE, Chibber S, Saad W. Patient-centered care and uterine fibroids. Semin Reprod Med. 2017;35:560–564.